Alzheimer’s Disease

San Mateo, California, USA, September 3, 2026 Kali Therapeutics announced that the U.S. Food and Drug Administration (FDA) has...

Irving, Texas, USA, September 2, 2026 Caris Life Sciences will present new research highlighting advances in precision oncology, molecular...

Stockholm, Sweden, August 21, 2026 Implantica AG has announced a major U.S. regulatory milestone after the U.S. Food and...

Dublin, Ireland, August 20, 2026 Keenova Therapeutics plc has announced that the first patient has been enrolled and dosed...

Atlanta, Georgia, August 20, 2026 Alzamend Neuro, Inc. has announced that data from its Phase 1/2A clinical trial of...

Naarden, The Netherlands, August 19, 2026 Kynexis, a clinical-stage biotechnology company developing therapies for cognitive disorders, has raised an...

Seongnam, South Korea, August 14, 2026 SK bioscience has submitted a Clinical Trial Application (CTA) to the South African...

MECHELEN, Belgium, August 10, 2026 Lakefront Biotherapeutics NV reported its half-year 2026 financial results and provided a business update...

FREMONT, California, August 10, 2026 Alamar Biosciences, Inc. announced an expansion of its strategic partnership with the Alzheimer’s Disease...

BOCA RATON, Fla., August 6, 2026 INmune Bio Inc. reported its second quarter 2026 financial results while highlighting significant...